Stanford anesthesiologist and writer Audrey Shafer reflects on the importance of considering the scientific and ethical issues raised by Frankenstein.
Stanford’s Abraham Verghese believes there should be a more nuanced conversation around what artificial intelligence can do for doctors.
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.
Researchers have found a way to turn off a key driver of inflammation in celiac disease, an autoimmune disease that affects millions of Americans.
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
Tuberculosis is a major public health problem worldwide, yet most people lack access to quick, reliable testing. Now, chemists have found a solution.
Stanford researcher Hiromitsu Nakauchi explores his dream of growing custom-made, transplantable human organs in large animals, despite funding difficulties.
Should research findings be moved to the clinic as soon as possible or should things move more slowly for patient safety? A med student explores the issues.
Stanford Storybank, organized by Stanford Health Care, collects 40-minute audio stories from patients and members of the Stanford Medicine community.
When gravely ill undocumented immigrants wait to seek health care, they’re less likely to have end-of-life care that follows their wishes.
A new study finds that young children’s brains have not yet fully developed the vision circuits they need to understand words and faces.
After Aditi Polamreddy's brain tumor was removed, she needed physical and occupational therapy to keep her brain from forgetting one side of her body.
The key to preventing dangerous Aspergillus fumigatus infections following lung transplant may be blocking iron, a new Stanford Medicine study has found.
New research suggests that targeting mitochondria could be a way to treat Parkinson's disease.
In this essay, medical student Natasha Abadilla reflects on the walls that medical trainees put up between themselves and their patients.
